And just for the record - since you have not spoken to me since my 'Hiatus' it is fascinating that you have reached the conclusion that I sound like K the Investor. You can't judge how I respond to an assho** who accuses me of this and that and extend this to how I sound like that other he/she/it idiot. If you or anyone else takes a cheap shot swipe across the bow then I have a right to respond - even if they use a profusion of <g>'s all over the place - that <g> thing is no license to give people the right to be sarcastic and smack people in public like so many people are wont to do - names unmentioned <g>.
Remember very clearly that this is not the same as saying something nasty face to face. THERE IS NO PLACE FOR THIS NONSENSE IN PUBLIC. IN PUBLIC. BUT IF YOU ATTACK ME THEN BE PREPARED TO FACE THE MUSIC AND, IF PUSHED, I CAN PACK A MEAN TUNE FOR A VERY LONG TIME. <g> Oh what the heck one more <g>.
<NFG>
The pot calling the kettle black.
<g>
Cheap swipes across the bow unappreciated. <g>
Making personal <g> observations of a negative <g> nature unappreciated <g> . Comparing <g> me to K the Investor <g> when I have said nothing <g> to you is just such a cheap shot and is just <g> such a personal observation of a <g> negative nature <g>.
<NFG> again.
Hit NEXT.
<NFG> yet again.
Ha Ha Ha... Life is so very very good. <gggggggggggggg>
-- ending song: Repeat 20--
'The base revenues for LSI were $1.85 billion in 1998. Except for a IPR&D accounting
writeoff (bogus), the Symbios assets that LSI bought were not subsequently written off.
What did take place was a $5.4 million Symbios Integration Accrual. Per the 10-K,
page 42, this accrual comprised '$4 million related to involuntary separation and
relocation benefits for approximately 300 Symbios positions and $1.4 million in other
exit costs primarily relating to the closing of Symbios sales offices and the termination of
certain contractual relationships.' Therefore it appears that the $75 mil restructuring
charge taken later was for the 'old LSI' and has very little negative bearing on Symbios
continuing operations. LSI valued Symbios at a fair value of $804 million - $324 million
for tangible assets, $214 million for current technology, $37 million for assembled
workforce and trademarks, $83 million for goodwill, and $146 million for IPR&D (this
part was written off). In this context, $5.4 million is puny and irrelevant. Symbios' assets
(read: ability to generate revenue) only strengthened after integration with LSI. They did
not weaken. Further, LSI has not indicated that they discontinued anything significant in
the Symbios product line. Because they used purchase accounting (versus pooling) LSI
can't use pro-forma Q1, Q2, Q3 or
full-year 1998 numbers going forward. It is NOT because, as Jock mumbles
grandiosely: "It would be a terrible disservice to the company, shareholders, and the
public in general.". Give me a freakin' break.'
--- |
